Patents
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
08/1999
08/19/1999WO1999021832A3 Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders
08/19/1999DE19806713A1 New urethane derivatives are used to inhibit cholesterol biosynthesis and to treat e.g. hyperlipidemia, cell proliferation diseases, mycosis etc.
08/19/1999CA2320381A1 Cytostatic agents
08/19/1999CA2320285A1 Anti-inflammatory agents
08/18/1999EP0935600A1 Method or producing naphthyridine compounds and novel intermediate products
08/17/1999US5939587 N-protected/N-substituted-beta-amino hydroxy sulfonates
08/17/1999US5939560 Inhibitors of DP-mediated processes, compositions and therapeutic methods thereof
08/17/1999US5939462 NPY5 receptor antagonists and methods for using same
08/17/1999US5939438 Insecticidal oximino and hydrazono derivatives of N-benzyl-4-benzhydryl-and N-benzyl-4-benzhydrol-piperidines
08/17/1999US5939411 Piperidine derivatives substituted at position 4 with new functions other than those described previously have a high affinity for neurokinin receptors and are useful for treatment of substance p and neurokinin dependent pathologies
08/17/1999US5939392 Thrombin inhibitors, anticoagulants and antiinflammatory agents
08/17/1999US5939381 4-(4-(phenoxyacetyl)aminophenyl)butyric acid as a carrier for drug delivery
08/17/1999CA2195622C Process for preparing trans-piperidine-2,5-dicarboxylates
08/12/1999WO1999040083A2 Bifunctional tryptase inhibitors
08/12/1999WO1999040073A2 Tryptase inhibitors
08/12/1999WO1999040070A1 N-acyl cyclic amine derivatives
08/12/1999WO1999039704A1 Antibacterial agents
08/12/1999DE19851299A1 Tryptase-Inhibitoren Tryptase inhibitors
08/12/1999DE19804980A1 Hydroxyl and uretedione group containing polyisocyanate, useful for production of polyurethane powder paints
08/12/1999CA2320476A1 Antibacterial agents
08/11/1999EP0934928A1 Cyclic amine derivatives
08/11/1999EP0934920A2 Preparation of hydrogenated compounds using noble metal Raney catalysts
08/11/1999EP0934316A1 Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use
08/11/1999EP0934313A1 N-substituted azaheterocyclic compounds
08/11/1999EP0934306A1 N-substituted azaheterocyclic compounds
08/11/1999EP0934293A1 Novel compounds and compositions for treating diseases associated with tryptase activity
08/11/1999EP0934291A1 Protease inhibitors
08/11/1999EP0934274A1 Substituted pyridines and biphenyls as anti-hypercholesterinemic, anti-hyperlipoproteinemic and anti-hyperglycemic agents
08/11/1999EP0934273A1 New derivates from piperidine-keto acid, their preparation and use
08/11/1999EP0934272A1 Synthesis of cisapride
08/11/1999EP0934271A1 Substituted arylalkylamines as neurokinin antagonists
08/11/1999EP0934263A1 Heterocyclic thioesters and ketones
08/11/1999EP0934080A2 1,3-bis-(n-lactamyl) propane and the pharmaceutical and cosmetic use thereof
08/11/1999EP0933993A1 Substituted cyclopentane compounds useful as neuraminidase inhibitors
08/11/1999EP0642509B1 Novel potent inducers of terminal differentiation and methods of use thereof
08/11/1999EP0584223B1 Novel immunosuppressive compounds
08/10/1999US5936128 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents
08/10/1999US5936114 Preparation of lactams from aliphatic α, ω-dinitriles
08/10/1999US5936091 Processes and intermediates for resolving piperidyl acetamide stereoisomers
08/10/1999US5936090 To the corresponding amino alcohols with yields greater than 76%. using as a reducing agent lithium aluminum hydride or the less costly sodium aluminum hydride
08/10/1999US5936089 Dipeptides which promote release of growth hormone
08/10/1999US5935998 Use of all allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection or associated diseases
08/10/1999US5935989 N-linked ureas and carbamates of heterocyclic thioesters
08/10/1999US5935976 Viricides, hiv
08/10/1999US5935974 Diphenylmethylene piperidine derivatives
08/10/1999US5935958 Muscarinic antagonists
08/10/1999US5935954 Compounds with improved multi-drug resistance activity
08/10/1999US5935951 1-acyl-4-aliphatylaminopiperidine compounds
08/10/1999CA2260698A1 Pyrrolidine and piperidine derivatives
08/05/1999WO1999038869A1 Therapeutic compounds
08/05/1999WO1999038846A1 Immunosuppressive agents
08/05/1999WO1999038827A1 PLATELET AGGREGATION INHIBITION USING LOW MOLECULAR WEIGHT HEPARIN IN COMBINATION WITH A GP IIb/IIIa ANTAGONIST
08/05/1999WO1999038514A1 Cyclic amine modulators of chemokine receptor activity
08/05/1999DE19803408A1 Alpha, alpha-disubstituted benzyl cyanide preparation in high yield and purity
08/05/1999CA2319781A1 Cyclic amine modulators of chemokine receptor activity
08/05/1999CA2319627A1 Therapeutic compounds
08/05/1999CA2318215A1 Platelet aggregation inhibition using low molecular weight heparin in combination with a gp iib/iiia antagonist
08/04/1999EP0933361A1 1,2-Di-substituted piperidine derivatives as hair growth promoter
08/04/1999EP0932598A1 ASPARTATE ESTER INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME
08/04/1999EP0854720B1 Nk-1 receptor antagonists for prevention of neurogenic inflammation in gene therapy
08/04/1999EP0848707B1 4-(cycloalkyl)piperidines and 4-(cycloalkylalkyl)-piperidines derivatives, preparation thereof and therapeutical applications thereof
08/03/1999US5932765 Nitromethyl ketones, process for preparing them and compositions containing them
08/03/1999US5932735 Stabilizers
08/03/1999US5932734 N-aminoalkylfluorenecarboxamides
08/03/1999US5932616 Potent inducers of terminal differentiation and methods of use thereof
08/03/1999US5932595 Antiarthritic agent; multiple sclerosis; osteoporosis; respiratory system disorders; skin disorders; antiulcer agent
08/03/1999US5932594 3-substituted piperidine derivative
08/03/1999US5932593 Antiserotonin agent
08/03/1999US5932587 Heterocyclic-fused pyridines
08/03/1999US5932586 Prostaglandin synthase inhibitors
08/03/1999US5932582 Fibrinogen receptor antagonist prodrugs
08/03/1999US5932559 Treatment of hyperandrogenic conditions
08/03/1999US5932538 Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
08/03/1999CA2170278C Inhibition of smooth muscle cell migration by (r)-amlodipine
07/1999
07/29/1999WO1999037651A1 Chemokine receptor antagonists and methods of use therefor
07/29/1999WO1999037623A2 Sulphonamide derivatives for treatment of cns disorders
07/29/1999WO1999037619A1 Chemokine receptor antagonists and methods of use therefor
07/29/1999WO1999037617A1 Chemokine receptor antagonists and methods of use therefor
07/29/1999WO1999037616A1 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress
07/29/1999WO1999037615A1 Method for producing (-)cis-3-hydroxy-1-methyl-4-(2,4,6-trimethoxyphenyl)-piperidine
07/29/1999WO1999020606A3 Piperidines and piperazines as platelet aggregation inhibitors
07/29/1999DE19802449A1 Preparation of 3-hydroxy-1-methyl-4-phenyl-piperidine derivative isomer, for use as intermediate for antitumor agent flavopiridol
07/29/1999CA2319077A1 Chemokine receptor antagonists and methods of use therefor
07/29/1999CA2318100A1 Chemokine receptor antagonists and methods of use therefor
07/29/1999CA2318088A1 Chemokine receptor antagonists and methods of use therefor
07/29/1999CA2317740A1 Sulphonamide derivatives for treatment of cns disorders
07/28/1999EP0918781A4 Asymmetric synthesis catalyzed by transition metal complexes with cyclic chiral ligands
07/28/1999EP0643693B1 Reversal of multi-drug resistance by triphenyl-piperidine derivatives
07/28/1999CN1224420A 1-alkyl-4-benzoyl-5-hydroxypyrazole compounds and their use as herbicides
07/28/1999CN1044365C Alpha, omega-diarylalkane derivs., their preparation and their use in treatment and prevention of circulatory diseases and psychosis
07/27/1999US5929266 Chiral organometallic compounds
07/27/1999US5929243 Process for the preparation of (S)-3-carbethoxy-3-benzylpiperidine
07/27/1999US5929242 Manufacture of levobupivacaine and analogues thereof from L-lysine
07/27/1999US5929117 Immunotherapeutic agents
07/27/1999US5929114 Administering antiviral compound which extrudes zinc from nucleocapsid protein of human immunodeficiency virus
07/27/1999US5929097 Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
07/27/1999US5929067 N-acylating amine derivative of caprolactam compound with a carboxylic acid or derivatives to form amide derivative of caprolactam compound
07/27/1999US5929054 Use of NK-1 receptor antagonists for treating sexual dysfunctions
07/27/1999US5928558 Storage stability
07/27/1999CA2164804C Nk-1 receptor antagonists for the treatment of neuronal injury and stroke